National Influenza Vaccine Task Force
The National Influenza Vaccine Task Force is an American federal government task force created by President Donald Trump composed of many government agencies and representatives.
History
On September 19, 2019, United States President Donald Trump issued Executive Order (EO) 13887: Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.1) The primary action of the EO was to create a National Influenza Vaccine Task Force in anticipation of an upcoming pandemic, focusing on ramping up “innovative, faster, and more scaleable technologies” than was previously used for influenza vaccines.
It additionally called for development and strengthening of public-private partnerships, including the transfer of technology to such partnerships, specifically mentioning the HHS Centers for Innovation in Advanced Development and Manufacturing. Shortly after, in December 2019, the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna signed an agreement to transfer their jointly-owned mRNA vaccine candidates to the University of North Carolina at Chapel Hill.2)
In August 2020, the task force published a report titled National Influenza Vaccine Modernization Strategy 2020-2030.3)
Organization
Members
The task force is co-chaired by the Secretaries of Defense and Health and Human Services, or their designees. Its main membership includes representatives from a variety of key federal agencies:
- Department of Defense (DOD)
- Department of Justice (DOJ)
Additional participants include:
- Department of State (DOS)